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Identification of bio-markers in
sarcoidosis bal using multidimensional
differential display proteome analysis
coupled with nano-hplc ms/ms
Otto F Villa1, Oscar E Guevara1, Marc Judson2,
Robert P Baughman3, and Michael Iannuzzi 1
1 Mount Sinai School Of  Medicine. New York, NY;
2 Medical University of  South Carolina. Charleston, SC.
3 University of  Cincinnati Medical Center, Cincinnati, OH,
United States.
otto.villa@mssm.edu
Abstract
It is well recognized that activated T-cells together with his-
tiocyte/macrohages accumulate in the interstitium and al-
veoli of  the sarcoidosis lung forming granulomas. The goal
of  this study is to perform a global analysis of  the sarcoido-
sis-macrophage proteome using multidimensional differen-
tial display to identify molecular species unique to this ILD.
To this effect CD14+ cells were isolated from the BAL of
sarcoidosis patients (n=10), patients with other ILDs (n=10)
or from patients with no ILD (n=4). Proteomes of  each
BAL were prepared using large format two-dimensional gel
electrophoreses. TiFF files were warped in reference to sar-
coidosis and all spots integrated into a large matrix.
A total of  23960 spots were analyzed, 1198 spots compri-
sed the sarcoidosis proteome, of  these 383 were up-regula-
ted over two-fold and 294 over 10 fold when compared with
proteomes of  the patients without ILD (Fig. 1). The sarcoi-
dosis proteome was next compared with all other ILDs in a
step-wise manner or globally, showing that 154 sarcoidosis
spots remained upregulated over 3 fold and 94 over 10 fold.
Protein identification by nano-HPLC-MS/MS on an LTQ
instrument revealed species involved in cellular metabolism,
calcium mobilization, actin binding, cell signaling, apopto-
sis, cell division and inflammation of  which 10 are being
studied as candidate biomakerkers.
C02
The clinical significance of IL2, IL12,
TGFbeta serum and balf levels in
sarcoidosis-a preliminary study
A Goljan-Geremek1, A Skoczylas1, U Demkow 2,
E Puscinska1, M Polubiec1, I Bestry1, D Gorecka1
1 Dept. of  Respiratory Medicine, Institute of  TB and Lung Di-
seases, Plocka, Warsaw, Poland
2 Dept. of  Laboratory Diagnostics and Clinical Immunology,
Warsaw Medical University, Poland
a.goljan@igichp.edu.pl
Abstract
There is evidence from clinical immunology that the serum
and BALF cytokine analysis may be useful for clinicians to
assess the extent and activity of  sarcoid inflammation.
Aim: To test the relationship between serum and BALF IL2,
IL12, TGFbeta levels and the clinical outcome of  sarcoidosis.
Methods: In 38 patients with biopsy proven sarcoidosis we
measured the serum and BALF IL2, IL12, TGFbeta levels
by the commercial sandwich ELISA kit from BioSource and
the non specific serum inflammation markers (proteinogram,
CRP, D-dimer, Fibrinogen,)
We compared the serum and BALF IL2, IL12, TGFbeta
levels, serum non specific inflammation markers in sar-
coid patients according to different clinical signatures of
the disease.
Results: The EN (n=5) was associated with high serum
alfa2globulin (p=0,03) and fibrinogen level (p=0,0002) and
low 02saturation during 6mWT (p=0,04).
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C03
Cytokine release from alveolar
macrophages in idiopathic
interstitial pneumonia
Qiao Ye, Ulrich Costabel, Josune Guzman1
Department of  Pneumology and Allergy, Ruhrlandklinik, Essen,
Germany
1 General and Experimental Pathology, Ruhr University, Bochum,
Germany
bjyeqiao@aol.com
Abstract
Object of study: Idiopathic interstitial pneumonia (IIP) is a
group of  interstitial pneumonias with unknown causes, clas-
sified as different subgroups according to the histological cha-
racteristics. Alveolar macrophages (AM) are able to release
various cytokines and play an important role in the inflamma-
tory and fibrotic process of  IIP. However, the production of
cytokines by AMs in the subgroups of  IIP is still unclear.
Methods: We measured the release of  TNF-alpha, TGF-beta,
IL-1beta, IL-6, IL-10, IL-12 and IL-18 from bronchoalveolar
lavage (BAL) macrophages in 9 patients with cryptogenic or-
ganising pneumonia (COP), 13 with non-specific interstitial
pneumonia (NSIP), 5 with respiratory bronchiolitis interstiti-
al lung disease (RBILD), 4 with desquamative interstitial pneu-
monia (DIP), 19 with idiopathic pulmonary fibrosis (IPF) and
10 controls. AMs were cultured for 24h with RPMI medium
alone or with lipopolysacchride (LPS) (100ng/ml). Cytokines
in the supernatants were measured by ELISA.
Results: The spontaneous levels of  TNF-alpha, TGF-beta,
IL-1beta, IL-6, IL-10, IL-12 and IL-18 released from BAL
macrophages were significantly higher in COP than in IPF
and controls (p<0.05 or <0.01 respectively), and except for
IL-18 also significantly higher in NSIP than in IPF and con-
trols (all p<0.05). The production of  these cytokines with
or without LPS stimulation was highest in COP, followed
by NSIP, and lowest in DIP/RBILD and IPF.
C04
Characteristics of myofibroblasts
(MyFb) recovered by bronchoalveolar
lavage in interstitial lung diseases (ILD)
Fireman E
Department of  Pulmonary and Allergic Diseases, 2National
Laboratory Service of  Interstitial Lung Diseases, Sackler Faculty
of  Medicine, Tel Aviv University, Tel Aviv, Israel
fireman@tasmc.health.gov.il
Abstract
We have developed a novel technique which allows to isola-
te myofibroblasts (MyFb)cells from the fluid recovered du-
ring bronchoalveolar lavage in patients undergoing this pro-
cedure for diagnostic porpoises. This method is crucial sin-
ce it gives us the possibility to achieve those cells also from
entities (like sarcoidosis, hypersensitivity pneumonitis) where
there is no clinical indication for open lung biopsy or thora-
coscopy. Most of  the studies in literature use animal model,
cell lines or cells recovered from lung surgery. The pheno-
type of  MyFb in sarcoidosis (SA) and idiopathic pulmonary
fibrosis (IPF) is unclear. We characterized the cytoskeletal
proteins and the contraction properties in alveolar-associa-
ted fibroblasts recovered by bronchoalveolar lavage (BAL)
in the two diseases. MyFb were studied from BAL cells in
eight IPF and seven SA patients. Cytoskeletal proteins were
identified by ELISA and immunofluorescent methods. Bio-
chemical measurements were done by dry chemistry. Con-
traction was performed by a gel contraction assay. MyFb
alpha-SM actin measured by ELISA was higher in IPF than
in SA. Vimentin, desmin, myosin, and fibroblast markers
were expressed equally. Only in IPF did the MyFb reveal the
myofibroblast phenotype showing alpha-SM actin immu-
nofluorescence labeling and, by electron microscopy, fila-
ments with associated dense bodies with rough endoplas-
mic reticulum. Gel contraction showed that cells in IPF
contracted significantly more than in SA. This may explain
the difference in the behavior patterns and outcomes of  the
two diseases. Recovery of  MyFb from BAL fluid open a
window to the mesenchymal cells research in ILD.
C05
Pulmonary alveolar proteinosis.
A report of turkish cases
N Mogulkoc, O Ozdemir, E Eryuksel1, N Kokturk2,
M Yuksel1, S Karakurt1, T Celikel1
Department of  Chest Medicine, Ege University, Izmir, Turkey;
1 Marmara University Hospital, Istanbul;
2 Gazi University Hospital, Ankara, Turkey
nmogulkoc@compuserve.com
Abstract
We review 15 patients (5 male and 10 female, mean age 37
years) with the diagnosis of  pulmonary alveolar proteino-
sis diagnosed and followed in three University Hospitals
in Turkey. The major clinical features were dyspnea, cou-
gh, and chest pain, with durations of  symptoms from three
months to five years. On chest radiography, there were bi-
lateral symmetrical alveolar opacities located centrally in
the mid and lower lung zones. High resolution CT (HRCT)
scanning revealed widespread ground-glass opacification
in nine cases and “crazy-paving” in the remainder. The di-
agnoses were established in all patients by transbronchial
biopsy or from fluid obtained at bronchoalveolar lavage
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(BAL). A total of  29 episodes of  whole lung lavage were
performed across 12 cases, using between 15 and 30 litres
per episode. Eleven cases had sequential right and left lung
lavages, twice in one case. The twelth case required five
separate episodes of  lavage on the left over a period of  six
years for progressive disease. In this case, the fourth lava-
ge resulted in severe hypoxemia and prolonged intensive
care unit (ICU) stay, probably due to an excess amount of
residue left in the lung: the fifth lavage was fatal after pro-
longed ICU stay due to ventilator-associated pneumonia
(VAP) and sepsis. Two of  the patients experienced spon-
taneous remission.
C06
Acute fibrinous and organizing
pneumonia (AFOP) in the ICU-case
report
Eduardo Sousa1, João Pedro Baptista1, Nuno Devesa1,
Lina Carvalho2, Jorge Pimentel1
1 Intensive Care Unit;
2 Pathology Department
University Hospital – Coimbra
j.eduardo.sousa@gmail.com
Abstract
Acute fibrinous and organizing pneumonia (AFOP) has
been recognized as a distinctive histologic pattern, which
does not meet the classic histologic criteria for diffuse
alveolar damage (DAD), BOOP, or eosinophilic pneu-
monia (EP) and may represent an underreported variant.
AFOP differs from the classic patterns of  DAD and or-
ganizing pneumonia in that organizing intra-alveolar fi-
brin constitutes the dominant histologic finding, and di-
ffers from the pattern of  EP by the lack of  prominent
eosinophils.
The authors report the case of  a 35-years old man admitted
to the hospital complaining of  sore throat, fever, cough and
muco-purulent sputum. In the same day he was admitted to
the ICU with the hypothesis of  community-acquired pneu-
monia. The patient suffered head trauma a few years ago
and there was no history of  drug addiction, was a non-
smoker and without other epidemiological risk factors. Des-
pite the use of  appropriate antibiotherapy and steroids, his
condition didn’t improve. He was always kept under mecha-
nical ventilation and developed multiorgan failure. Blood,
tracheo-bronchial aspirate, bronchoalveolar lavage (BAL) and
urine microbiological tests were negative. BAL showed ex-
treme neutrophilic alveolitis (N: 75%; L: 12%; E: 2%; M:
9%; CD4/CD8: 1,3) with normal cell count (133/mm3).
Autoimmunity tests were negative. Lung biopsy was com-
patible with AFOP.
The evolution of  this patient was fatal after 20 days in the
ICU. According to some literature there are no identifiable
clinical or histologic parameters predictive of  patient ou-
tcome with the exception of  those who need mechanical
ventilation that have a worse prognosis. An optimal therapy
is not clearly identified.
C07
A 45-year-old man with a persistent
cough
J Cemlyn-Jones, F Gamboa, C Robalo Cordeiro,
MF Baganha
Department of  Pneumology and Allergology, University Hos-
pital Coimbra
jcemlynjones@yahoo.com
Abstract
A 45-year-old man was referred to a pulmonologist because
of  a five-month history of  cough productive of  sputum,
exertional dyspnea, wheezing and fatigue. He had no fever,
chills or nocturnal sweats.
The patient was a businessman. He did not smoke or abuse
alcohol and took no customary medication. He bred chi-
ckens, pigeons, turtle-doves and canaries.
The Chest radiograph revealed a bilateral reticulonodu-
lar pattern and high resolution CT scan findings inclu-
ded ground-glass attenuation. Lung function tests sho-
wed restrictive ventilatory defect and reduced transfer
factor. Bronchoalveolar lavage had significant increase
in the total cell count (740.0/mm3) and contained high
absolute and relative numbers of  lymphocytes (80%).
Analysis of  T-cell surface phenotypes revealed strong
predominance of CD 8 T cells associated with a redu-
ced CD4/CD8 ratio (0.4). Laboratory findings included
precipitating antibodies in pigeon’s feathers, droppings
and serum (titre 175).The patient was admitted to the
hospital for a CT-guided needle biopsy. Histopatholo-
gical evaluation of  lung tissue revealed an interstitial
infiltrate of  lymphocytes, plasma cells, neutrophils and
eosinophils.
The features of  this case strongly suggest hypersensitivity
pneumonitis.The culprit antigen was defined and the pigeons
were removed so as to avoid continued antigen exposure.
Additionally, the patient was treated with oral methylpred-
nisolone followed by gradual taper.There was significant cli-
nical and functional improvement.
Hypersensitivity pneumonitis is a granulomatous immuno-
logic response of a sensitized host to inhaled biological ae-
rosols. In the case of  pigeon breeder’s disease, high levels of
bird antigen may persist for prolonged periods of  time, des-
pite removal of  the offending birds.
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C08
Diagnostic value of surgical lung
biopsy in diffuse pulmonary disease:
Comparison with clinical and
radiological diagnosis
Gonçalo F Coutinho, Rita Pancas, Eunice Magalhães,
João E Bernardo, Manuel J Antunes
Cardiothoracic Departamento de Cirurgia Cardiotorácica. Hos-
pitais da Universidade de Coimbra. Portugal
goncalocoutinho@yahoo.com
Abstract
Objective: Surgical lung biopsy (SLB) is considered the fi-
nal method of diagnostic modality in patients with undiag-
nosed diffuse pulmonary disease. Nevertheless, the effect
of  SLB on the diagnosis, treatment and outcome of  the
patient still remains controversial. The goal of  this study
was to verify the concordance of  the preliminary diagnosis,
based on non- invasive or minimally invasive diagnostic
methods (HRCT scan, PET, bronchoscopy), with the pa-
thological result of the SLB and the impact of the latter on
the treatment of  those patients.
Methods: Retrospective review of  the experiences of  SLB
in our Institution, through VATS or mini-thoracotomy, in
280 consecutive patients during the past 5 years. The initial
diagnosis was based on clinical settings, images and non in-
vasive or minimally invasive diagnostic procedures and was
compared with the pathological findings. We considered 3
major groups: diagnostic concordance (DC); new diagnosis
(ND, including cases where there wasn’t a prior diagnosis);
and inconclusive (IC).
Results: Initial diagnosis included interstitial lung disease
(34.6%), metastasis (33.9%), primitive neoplasm (10%), in-
fectious pneumopathy (5%), others (2.5%) and no diagno-
sis (14%). The pathologic diagnosis after SLB comprised
interstitial lung disease (40.7%), metastasis (20.7%), primiti-
ve neoplasm (14%), infectious pneumopathy (5.3%) and
other lesions (13.6%). In 53.9% of  patients there was a DC,
in 40.4% a ND and 5.7% were IC. In 28.2% of  the primitive
pulmonary neoplasms the final diagnosis was unexpected.
In 38.9% of  patients with an initial metastatic diagnosis, this
was excluded. For most patients (94.8%) with suspicion of
interstitial disease a specific diagnosis could be made after
SLB. There wasn’t operative mortality and the morbidity was
1.0%.
Conclusion: SLB is a safe and accurate diagnostic tool
for pulmonary infiltrates of  unknown aetiology, with mi-
nimal operative morbidity and mortality. In our series,
there was a significant discrepancy between the clinical/
imagiologic findings and SLB, suggesting this diagnostic
modality has the “gold standard” in undiagnosed diffuse
pulmonary disease.
C09
Constrictive bronchiolitis – case report
A Reis, A Segorbe Luís, MF Baganha
Serviço de Pneumologia/Departamento de Ciências Pneumoló-
gicas e Alergológicas dos Hospitais da Universidade de Coimbra.
Portugal.
antonioreis3@sapo.pt
Abstract
The authors present a 35 year-old caucasian female patient,
former-smoker, who worked for 10 years in an archeologi-
cal field, with dyspnea, wheezing, productive cough and
malaise in the last 5 months. Wheezing and rhonchi were
present on chest auscultation.
The complementary evaluation revealed peripheral blood
eosinophilia (9.9 % of the leucocyte differential-1000 cels/
uL), mild hypoxemia (PO2-76 mmHg, breathing room air)
and mild obstructive ventilatory deffect with normal diffu-
sion capacity (TLCO). HRCT scan displayed diffuse ground
glass attenuation, patchy peripheral opacities and air-trap-
ping. Bronchoalveolar lavage showed neutrophilia (80%) and
eosinophilia (8%) and a CD4/CD8 ratio of 0.9; the culture
was positive for Branhamella catarrhalis. Transbronchial lung
biopsy was inconclusive.
HRCT scan after an antibiotic course, besides ground glass
attenuation areas, showed pulmonary infiltrates with a di-
fferent distribution.
Anti-nuclear antibodies, anti-neutrophil cytoplasmic antibo-
dies, immediate hypersensitivity skin test to Aspergillus, se-
rum Aspergillus-specific IgE and IgG were negative.
VATS lung biopsy was consistent with constrictive bronchiolitis.
After two weeks of  treatment with prednisone (0,75 mg/
Kg/day) there was complete resolution of  the symptoms as
well as normalization of  ventilatory impairment.
C10
Inflammatory markers in the
bronchoalveolar lavage fluid and
exhaled breath condensate of
patients with pulmonary sarcoidosis
J Chorostowska-Wynimko, A Rozy, J Czerniawska,
A Stepniewska, E Puscinska, A Geremek, S Wesolowski,
D Gorecka
National Institute of  Tuberculosis and Lung Diseases, Warsaw,
Poland
j.chorostowska@igichp.edu.pl
Abstract
The relationship between proinflammatory markers con-
centration in bronchoalveolar lavage (BAL) and expired
breath condensate (EBC) as well as cytology of  the respi-
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ratory tract obtained from BAL in sarcoidosis patients have
not been evaluated. To examine this we analysed the levels
of  TNF-alpha, IL-6, VEGF, IGF-1 and PAI-1 in the EBC
of  patients with pulmonary sarcoidosis, also in compari-
son to their concentration in BALF. The relationship be-
tween cytokines concentration in EBC and BALF and other
disease activity markers (BAL cytology, respiratory functi-
on measurements) has been evaluated as well. Most cytoki-
nes concentrations in breath condensate, as assessed by
Elisa method, were comparable to and highly correlated
with their levels observed in BALF: respectively TNF-al-
pha (3,79±1,78 pg/ml vs 3,34±2,81, r=0,7945, p<0,001),
IGF-1 (7,76±5,9 ng/ml vs 6,09±4,44, r=0,9356, p<0,001),
PAI-1 (0,81±0,42 pg/ml vs 0,94±0,43, r=0,8064, p<0,001).
As an exception, there was no correlation between VEGF
levels in condensate (31,99±10,57 pg/ml) and BALF
(27,15±.6,71, r=0,03) as well as negative correlation for
IL-6 (0,226±0,08 pg/ml vs 4,08 ±0,53, r=-0,469, p<0,01).
Significant positive correlation between relative macropha-
ge count in BAL and condensate content of  PAI-1 and
TNF-alpha as well as negative with IGF-1 was observed.
Pulmonary function as assessed by TLco measuremet cor-
related with IGF-1 levels in condensates (r=0,725) and
BALF (r=0,8215) only. Our data prove that quantitative
evaluation of  inflammatory markers in the expired breath
condensate of  sarcoidosis patients is possible. However
EBC usefulness for noninvasive monitoring of  certain
markers disease activity needs further evaluation.
C11
Identyfication of t regulatory cells
in the balf by flow cytometry
Joanna Domagala- Kulawik
Department of  Pneumonology Warsaw Medical University. Po-
land
jokual@amwaw.edu.pl
Abstract
Immunologic alterations play important role in the patho-
genesis of  many lung disorders like: interstitial lung disea-
ses, chronic obstructive lung disease, lung cancer. It was
shown0that regulatory T cells (Treg, CD4+/ CD25+) play
important role in the autoimmunity and regulation of  host
immune response.
The objective of  this study was determination of  lym-
phocyte subpopulation: T regulatory cells derived from
bronchoalveolar lavage fuid (BALF) and from peripheral
blood (PB).
Methods: We investigated patients with different lung di-
seases (pulmonary fibrosis, sarcoidosis, lung cancer, leuka-
emia) and healthy persons. BAL was performed routinely
and the total and differential cell count was evaluated by
microscopic examination. Flow cytometry method with the
pairs of monoclonal antibodies anti: CD14/ CD45 and
anti: CD4/CD25 was used for evaluate proportion of  Treg
cells. Expression of  Fas on Treg cells was analysed using
CD95/Cy5 antibody.
Results: Treg cells were identified in the BALF and in
PB, as well. The median proportion of  CD4+/ CD25+
cells as a percentage of  lymphocytes in the BALF was
6.7% (range: 0.7%- 18.6%) and in the PB was: 14% (ran-
ge 3,6% – 39%). These cells composed mean 29% of
CD4+ BALF lymphocytes and 38,4% of  PB CD4+ lym-
phocytes. We identified two populations of  CD4+/
CD25+ cells: with low and high expression of  CD25. The
last may represe~t the real population of  T regulatory
cells. The mean proportion of  CD4+/ CD25+ lympho-
cytes with high intensity of  fluorescence in the BALF
was 1,9% of  the pool of  lymphocytes and about 30% of
the pool of  CD4/CD25+ cells. About 100% of  BALF
Treg cells were positive to Fas receptor.
Conclusion: Identification of  Treg cells in the BALF is pos-
sible by flow cytometry.
C12
11 years of BAL experience
in Romania
Aneta Serbescu, Luminita Cervis, Cristina Teleaga
“Marius Nasta” Institute of  Pneumology, BAL Laboratory, Bu-
charest, Romania
anetaser@yahoo.com
Abstract
Background and aim of  the work: Bronchoalveolar lavage
(BAL) is an extremely useful method for sampling cells and
mediators from lower respiratory tract. We started our rese-
arch lab from zero, and built up to a national excellence cen-
ter in 11 years.
Method and results: 10320 products (BAL and bronchial
lavage, BL) fluids have been processed, from patients aged
between 6 and 88 years; over the 11 years of  development,
the bronchological sampling techniques have been impro-
ved (increased vitality of  up to 95-98%; recovered vol. 70-
75% and recovered cells 12-40 mil), together with gaining
and securing the interest and trust of  the pneumologists in
the method’s capacities.
Conclusions: Started in March 1995, our laboratory (the
only one with this profile in Romania) managed to dismiss
the insecurities of  the medical community regarding the use
of  BAL as a powerful diagnostic and follow-up tool; the
results will be presented following all etiological categories
investigated; the technique has also been widely used for
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TB-BL, considering the still very high incidence of  tubercu-
losis in Romania (120 o/oooo).
Outlook: The big diversity and the huge number of  lung
disease cases we are faced with offers a wide perspective for
research studies using BAL as a method for the better phy-
siopathological understanding of  the ensemble of  events
taking place in the human lung.
C13
Humoral immune response against
mycobacterial antigens in BAL fluid
from tuberculosis patients
U Demkow1,2, A Goljan-Geremek1, M Filewska1, B Bialas1,
TM Zielonka1, M Sobiecka1, J Ku1, E Augustynowicz-Kopec1,
Z Zwolska1, E Rowinska-Zakrzewska1
1 2Dept of  Laboratory Diagnostics and Clinical Immunology
of  Developmental Age, Warsaw Medical University;
2 Institute of  Tuberculosis and Lung Diseases, Plocka 26, Warsaw,
Poland
demkow@litewska.edu.pl
Abstract
The resistance to TB is cells-mediated but humoral response
is common and may be correlated with the lack of  effective
local cellular defence mechanisms. The goal of  the study was
to evaluate IgG, IgA and IgM mediated humoral immune res-
ponse against 38kDa and 16 kDa or 38kDa and LAM myco-
bacterial antigens in BAL fluid from patients with tuberculo-
sis (TB) compare to non-tuberculous controls (NTB).
179 BAL fluids (BALF) (56 TB, 123NTB – 74 non-specific
pulmonary infections, 19 lung cancer, 14 sarcoidosis, 14
mycobacterial infections other than tuberculosis, 2 healthy
controls) were examined. Commercially available ELISA –
based assays were used. Cut off  established according to
serial dilution and ROC curves. Mean IgG level against 38 +
16kDa was significantly higher in tuberculosis group com-
pared to control (p<0,05 Three different dilutions of  BALF:
1: 1; 1: 10 and 1:50 (100) were tested. Only for dilution 1: 10
obtained results allowed to differentiate TB group and con-
trol group. Mean IgG level against 38 + LAM was signifi-
cantly higher in TB group compared to control (p<0,0001).
Mean IgA and against 38kDa + LAM level was also higher
in TB group compared to NTB (p<0,05). No difference was
observed between TB and NTB group in titer of  IgM anti-
bodies. The findings of  the study indicate that TB is associ-
ated with the presence of  detectable levels of  antibodies in
the BAL F. Antibody response is highly heterogeneous. This
phenomenon results from the balance between pathogen
and host immune system. Examined tests detecting IgG in
BALF can be used in combination with other diagnostic
methods to increase diagnostic accuracy of  pulmonary TB.
C14
Immuno-diagnosis of TB using BAL
or induced sputum
RAM Breen, SM Barry, FM Perrin, G Janossy, MCI Lipman
Royal Free and University College Medical School
r.breen@medsch.ucl.ac.uk
Abstract
Objective: To examine the role of  bronchoalveolar lavage
(BAL) and induced sputum (IS) in the immunological inves-
tigation of  possible tuberculosis (TB).
Methods: BAL was incubated overnight with no antigen or
PPD. Cells were fixed, permeabilised and then stained with
monoclonal antibodies against CD3, CD4 and IFN;. The
percentage of  PPD-specific IFN; synthetic CD4+ T-lym-
phocytes (%CD4+IFN+) was identified using flow cyto-
metry. Responses were also examined in IS and whole blood.
Results: 238 individuals had BAL. 111/238 were diagno-
sed with active TB with a median [range] %CD4+IFN+
of 13.45% [0-79.11%]. 106/111 (95%) had %CD4+IFN+
>1.5%. Median %CD4+IFN+ for 127 without active TB
was 0.10% [0-27.10%]. 97/127 (76%) had %CD4+IFN+
<1.5%. Median %CD4+IFN+ in whole blood for 58 acti-
ve TB cases was 0.19% [0-1.63%]. Positive and negative
predictive values for active TB using a 1.5% cut-off  in BAL
were 78% and 95%. The assay worked well with HIV and
also extra-pulmonary TB. In pulmonary TB assay sensiti-
vity was 93% versus 77% for nucleic acid amplification
testing. Most subjects with %CD4+IFN+ >1.5% without
active TB had evidence of  previous TB. 10 TB patients
had paired BAL and IS. Median BAL %CD4+IFN was
12.05% [2.63-61.04%] versus 11.16% [0.51-23.79%] in IS.
In total, 26 TB patients had IS with median %CD4+IFN+
of 4.49% [0-23.79%] (%CD4+IFN+ >0.5% in 24/26;
>1%.in 22/26).
Conclusions: BAL and IS can be used in a highly sensitive
diagnostic TB immunoassay with advantages over blood.
C15
Bronchoalveolar lavage in
pulmonary tuberculosis diagnosis
R Gerardo, L Flora, A Borba, A Mineiro, J Cardoso,
R Matos
Hospital de Santa Marta
ritagerardo@netcabo.pt
Abstract
Introduction: Early identification and diagnosis of  active
pulmonary tuberculosis (PTB) cases is essential to any pro-
gram intended to control the spread of  this significant public
health problem. Due to the high incidence of tuberculosis in
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Portugal (39/100 000), all the patients studied in our bron-
chology unit are submited to mycobacteriological evaluation.
Objectives: Evaluate the diagnostic accuracy for PTB of
bronchoalveolar lavage (BAL).
Material and methods: We conducted a retrospective re-
cord review of  all patients with pulmonary tuberculosis di-
agnosed in our bronchoscopy unit, between January 1999
and December 2005, who were submited to flexible bron-
choscopy with bronchial lavage (BL) and BAL. 237 patients
were included (168 males and 69 females),with mean age of
44,7 years (range 20-85). 86 (36,2%) patients were HIV+.
BAL and BL samples were tested for Ziehl-Niessen (ZN)
and Lowenstein-Jensen (LJ).
Results: 214 (90%) patients were diagnosed with BL samples
and 141 (59,5%) with BAL. 23 (10%) patients were positive
only in BAL samples. 186 of  the 214 with BL samples pre-
sented LJ positivity and 28 had only ZN positive. In the 141
BAL samples, 109 had positive LJ and 32 had only ZN.
Conclusions: BL was more accurate in diagnosing PTB
(90%) than BAL but 10% of  the patients needed the BAL
samples positivity for diagnosis.
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RBILD – clinicopathologic features
S Freitas, C Robalo Cordeiro, B Rodrigues, A Catarino,
MJ Matos, I Ferreira, L Carvalho, MF Baganha
Departamento de Ciências Pneumológicas e Alergológicas
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Abstract
Background & aim: Respiratory Bronchiolitis (RB), des-
cribed by Niewoehner et al in 1974, is a common finding in
heavy smokers and is characterized by the presence of  pig-
mented macrophages within respiratory bronchioles and
adjacent alveoli. Later, Myers et al described RB associated
with interstitial lung disease (RBILD). The aim of  this study
is to analyse a group of  8 patients with biopsy-proven RBILD
diagnosed within the last five years, assessing epidemiologi-
cal data, clinical and imaging features, lung function tests,
bronchoalveolar lavage findings, therapeutic approaches and
clinical evolution.
Results: The patients ranged from 28 to 63 yr of  age and
included 7 men and 1 woman. All were current smokers(13-
60 pack years). All were symptomatic at presentation, with
productive cough and shortness of  breath being the com-
monest symptoms. Chest radiography showed predominan-
tly reticular or reticulonodular shadowing, confirmed by CT
scan but also showing ground glass opacification in 5 pati-
ents. Both restrictive and obstructive patterns were found in
lung function tests, with a gas transfer deficit in 4 patients.
Bronchoalveolar lavage was performed in 5 patients, revea-
ling consistently a CD4/CD8 ratio lower than 1. The treat-
ment of  choice was smoking cessation and conservatory
measures. All patients but 1 have remained stable or impro-
ved after a mean follow-up of  22 months.
Conclusions: The authors support that the diagnosis of
RBILD should require an appropriate clinical setting (inclu-
ding smoking habits), specific imaging findings (like ground
glass shadowing and centrilobular nodules), and the patho-
logical confirmation, obligatory in the exclusion of  more
adverse interstitial lung disease, namely idiopathic pulmo-
nary fibrosis.
C17
Differential cell count of
bronchoalveolar lavage in healthy
volunteers depends on volume
J Müller-Quernheim, A Prasse, M Rothe, UF Senge,
H Hamm, M Ziegenhagen, G Zissel
Dep. of  Pneumology, University Medical Center, Freiburg,
Germany
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Abstract
Bronchoalveolar lavage (BAL) is frequently used in the di-
agnostic work-up of  patients with suspected interstitial lung
diseases and its differential cell count may direct further cli-
nical evaluation. To this end normal ranges are required.
However, differential cell count depends on lavage volume,
processing techniques, and smoking status. In this study we
kept the BAL processing in the laboratory constant and
analyzed the influence of  volume and smoking status in a
large cohort of  98 healthy individuals (57 non-smokers (NS),
41 smokers (SM)). Volume was categorized in low (LO, 100
to < 300 ml, median: 120 ml, n = 23), medium (ME, 300 to
< 500 ml, median: 300 ml, n = 54), and large (LA, 500 to
700 ml, median: 600 ml, n = 19).
Recovery was similar in all volumes used ranging from 64 ± 8
% in ME to 76 ± 10 % in LA. A close correlation between BAL
volume and cell recovery was observed in NS and SM (p<0.0001
and p<0.005 resp.) with up to 19 million and 56 million cells
per 100 ml recovered BAL of  NS and SM, respectively. In both
NS and SM differential cell count was also influenced by volu-
me with higher percentages of  lymphocytes and lower percen-
tages of  alveolar macrophages in LA and vice versa in LO.
Percentage of  neutrophils was higher in LO than in ME and
LA without significant differences between NS and SM. Only
low numbers of  eosinophils were observed without significant
differences between volumes and smoking status.
Normal ranges for the three volume categories for NS and
SM will be presented.
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Bronchoalveolar lavage fluid (BAL)
in diffuse parenchymal drug related
lung disease: Report of a series
M Romagnoli1, M Chilosi2, GL Casoni1, C Gurioli1,
L Serra3, V Poletti1
1 Department of  Thoracic Diseases, Forlì, Italy,
2 Department of  Pathology, Verona, Italy,
3 Department of  Pathology, Forlì, Italy
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Abstract
Background: Diffuse parenchymal drug related lung dise-
ase is an increasing cause of  potentially fatql acute or chro-
nic pulmonary disease. Its identification is often complex
and one of  exclusion. Therefore, pathological data in corre-
lation with clinical, laboratory and radiological features are
helpful and might be often all necessary together for a defi-
nitive diagnosis.
Subjects and Methods: We retrospectively analyzed thir-
ty-four subjects (23 males, 11 females; mean age 56.8±16)
with diffuse parenchymal drug related lung disease, develo-
ped in 21 patients with baseline malignancy after a treat-
ment with anti-neoplastic drugs in a chemotherapy regimen
(oncological group), and in 13 patients with non-neoplastic
baseline disease, treated by a single agent (non-oncological
group). All patients underwent fiberoptic bronchoscopy
(FBS) with bronchoalveolar lavage fluid (BAL) and trans-
bronchial biopsies. In 4 cases a surgical lung biopsy was also
performed.
Results: BAL findings were represented by: an increase in
total cell number (>150.000/ml3) in 20 patients of  the total
34 (58.8%); lymphocytosis (lymphocytes >15% of total
cells) in 21 patients (61.7%); neutrophilia (neutrophils >4%
of total cells) in 24 patients (70.5%); eosinophilia (eosino-
phils >2%) in 11 patients (32.3%). A decreased CD4+/
CD8+ ratio (CD4+/CD8+ <1%) was found in 20 pati-
ents (58.8%), and an increased CD4+/CD8+ ratio (CD4+/
CD8+ >2.4%) in 5 patients (14.7%). BAL was diagnostic
per se in 8 cases of  the total 34 (23.5%): 5 were lipoid
pneumonia, 2 alveolar haemorrhage and 1 eosinophilic
pneumonia. The most frequent histological patterns were:
cellular interstitial pneumonitis (CIP) in 29.4% of cases
(n=10), organizing pneumonia (OP) in 23.5% (n=8), di-
ffuse alveolar damage (DAD) in 17.6% (n=6), lipoidic pneu-
monia in 14.7% (n=5), the remaining being alveolar hae-
morrhage, hypersensitivity pneumonitis and eosinophilic
pneumonia. Patients with a DAD pattern presented signi-
ficantly higher neutrophils in BAL as compared to pati-
ents with CIP, OP and HP (p=0.03). Although BAL lym-
phocytes showed a tendency to be higher in patients with
CIP/OP/HP, they did not reach statistical significance, pro-
bably due to the low number of  patients with DAD (n=6).
Four oncological and 1 non-oncological patient died, all
presenting with type II reactive cells in BAL fluid, 4 with a
DAD pattern, 1 with CIP.
Conclusions: our series suggest that in most cases of  di-
ffuse parenchymal drug related lung disease, neither BAL
findings nor lung biopsies are specific per se for diagnosis,
but clinical, laboratory and radiological data are also neces-
sary. However, BAL might be diagnostic per se in some spe-
cific patterns of  diffuse parenchymal drug related lung dise-
ase, e.g. lipoid pneumonia, alveolar haemorrhage and
eosinophilic pneumonia, without need for other invasive
procedures. Moreover, BAL seem to have a prognostic role
in these diseases.
C19
Pulmonary alveolar proteinosis
(PAP): A case of successful pregnancy
Ana Cristina Mendes, Cliff  Morgan1, M Felizardo,
Renato Sotto-Mayor, A Bugalho de Almeida
Serviço de Pneumologia Hospital Santa Maria, Lisboa. Portugal.
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Abstract
There are very few reports on PAP and pregnancy. We re-
port a case of  successful pregnancy in a patient with PAP.
A 36 year old female was first symptomatic at age 19. At
age 23, after a lower respiratory tract infection, she was
diagnosed as having PAP by pulmonary biopsy. Since then,
multiple whole lung lavages (WLL) were performed when
she was symptomatic. Otherwise she led a normal and ac-
tive life despite important lung disease observed on chest
x-ray and HRCT, and moderate restrictive lung disease. A
set of  two consecutive WLL (right and left) were done
before she attempted to become pregnant. By the 25th week
of  pregnancy she noticed increased tiredness and she was
found to dessaturate down to 88% with minimal exertion
and she was started on supplemental oxygen with good
result. At week 28 she was re-evaluated with HRCT which
confirmed moderately severe PAP but no other new or
different pathology. By this time her SaO2 was slightly
better and it was decided that the risks of  general anaes-
thesia and WLL were not justified and conservative mana-
gement continued. Her SaO2 remained stable at greater
than 90% from then on. She delivered at week 38 and 6
days pregnancy. An elective caesarean section under epi-
dural anaesthesia was done and a healthy baby was delive-
red (Apgar 9/10). Prior to delivery her PaO2 in room air
was 52 mmHg, 24 hours after delivery was 58.4 and 3 days
latter was 79.8 mmHg.
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BALF CCR5 and CXCR4 receptors
in HIV infection
M Alcide Marques1, Vera Alves, MA Santos Rosa,
MF Botelho, A Meliço-Silvestre, MF Baganha
1 Pneumologic Department of  Coimbra University Hospitals.
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Abstract
The discovery that specific chemokine receptors act as co-
receptors for HIV, allowed a better understanding upon the
mechanisms underlying viral cellular entry and tropism.
Aims: To evaluate the expression of  CCR5 and CXCR4 in
BAL fluid from HIV infected patients, submitted to bron-
choscopy for detection of  opportunistic lung infections.
Material and Methods: 14 patients (9 males, 5 females),
aged 39.6 ± 14.3 years, all HIV1 heterosexuals. In BAL fluid
and in peripheral blood, we studied the receptors: CCR5,
CD4 CCR5, CD8 CCR5, CCR5 M0, CXCR4, CXCR4 CD3,
CXCR4 CD14, as well as the co-stimulatory molecule CD28,
CD28 CD3, CD28 CD4, CD28 CD8 through monoclonal
antibodies and flow citometry. In the statistical analysis, a T-
Studant test and linear correlation was used.
Results: Drop of  CD28 co-stimulatory factor in BALf; in-
crease expression of  CCR5 M0 in BALf  compared with the
peripheral blood; statistical significant differences between
BALf  and blood for the CXCR4 (p<0.02), CXCR4 CD3
(p<0.006), CXCR4 CD14 (p<0.00002).
Conclusions: The lost of  CD28 co-stimulatory factor is pro-
bably related with immunological senescence. Both CCR5 and
CXCR4 had an increased expression in BALf  of  these pati-
ents, particularly the CCR5 M0 and CXCR4 CD14, meaninw
the important activation of  lung macrophages. The over-ex-
pression of  these receptors may have important implications
in future therapeutic approaches, such as, its blockage.
C21
Smoking exposure effect on
cytological and apoptotic parameters
of BAL in smoking and NSCLC
Svetlana Zunic, Snezana Zunic, Ljubisa Rakic
Clinical center of  Serbia, Institute of  Nuclear Medicine, Labo-
ratory for Microanalytic Diagnostics
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Abstract
Smoking exposure, as one of  etiopathogenic factors of  malig-
nant lung diseases was investigated in relation with bronchoalve-
olar lavages (BAL) cytological and apoptotic parameters. BAL
was performed in13 examinees; 7 of  them were patients with
diagnosis of NSCLC (Non-Small-Cell Lung Cancer). Apoptotic
parameters in BAL specimens stained by TUNEL and differen-
tial cell counting of  BAL specimens were performed using light
microscopy. Smoking exposure (pack-years) was significantly hi-
gher in NSCLC patients in comparison with control smokers:
44.07±21.33 vs 1.8±1.6 (p<0.001). Significant increases of eosi-
nophils (p<0.01), neutrophils (p<0.05), lymphocytes (p<0.05)
and decrease of  alveolar macrophages (AMs) (p<0.01) were found
in patients with NSCLC in comparison with control smokers.
Significant correlations of  relative per cents of  Foamy AMs and
stage of  apoptotic cells internalization by AMs and mast cells
(r=-0.87, p<0.05 and r=+0.93, p<0.05, respectively) were found
in control smokers. Nonparametric correlation analysis showed
that significant correlations between Foamy AMs and apoptotic
markers existed in control smokers. In NSCLC patients, signifi-
cant correlations were found between eosinophils and mast cells
and apoptotic parameters.Thus, cumulative effect of  smoking
exposure might be of  great interest in observation of  smoking
induced tissue injury leading to oncogenesis.
C22
Apoptosis of alveolar lymphocytes
(AL) in interstitial lung diseases (ILD):
Its extension, alterations and clinical
importance
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Abstract
Background: Activity of  inflammation in ILD depends in-
ter alia on decreased apoptosis of  alveolar lymphocytes, AL.
The extension of  this process, its relation to other inflam-
matory markers, as cytokine secretion, and its clinical im-
portance needs explanation.
Methods: AL and AM obtained from patients with silicosis, as-
bestosis, sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF)
(n=13,18,57,18 resp.) were examined for: 1. cell cycle (sub-G1
late apoptosis peak) 2. TUNEL 3. Annexin V, Fas, Fas Ligand
(FasL), BCL-2 and caspase-3 expression. 4. BAL routine cytology
and immunotyping. BAL supernatants were tested with ELISA
for IFNã; TNFá; IL4, IGF1, soluble Fas (sFas) and soluble FasL
levels. Cell short-term cultures were performed in some cases.
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Results: Average 1% of  AL enters apoptosis (and 1% prolifera-
tes) in controls as detected by cell cycle analysis. Decreased AL
apoptosis rate was found in Loeffgren’s syndrome (LS), progres-
sive PS and asbestosis (0.6±0.2, 0,5±0.2, 0.4±0.15 vs 1.1±0.5%
in controls, median ± SEM). AL apoptosis rate was negatively
correlated with total CD4 cell number (rs -0.33, p<0.02) and
CD4/CD8 ratio (rs -0.25, p<0.005). Additionally, in 3 PS pati-
ents with subsequent disease remission massive AL apoptosis
(up to 50% of  cells) was observed. Serial BAL examinations per-
formed in 7 cases of  chronic PS showed increased AL apoptosis
towards the rate observed in controls. Systemic steroid treatment
in 3 PS and 5 IPF patients resulted in dramatic increase of AL
apoptosis rate but had no influence on AM apoptosis.
TNF&#945; levels (significantly increased in LS, active PS, IPF
and asbestosis) were negatively correlated with percentage of
apoptotic AL (rs -0.31, p<0.001). Except negative correlation
between sFas and AL apoptotic rate (p<0.05) other mediators
seemed have no influence on BAL cell apoptosis (the observati-
on proven additionally by BAL cell cultures).
Conclusions: 1. AL accumulation in ILD depends in part
on AL apoptosis decreased rate. 2. Inhanced AL apoptosis
may be applied as a marker of  clinical improvement and/or
local impact of  steroid treatment. 3. TNF&#945; and Fas,
but not IFNγ, IL4 or FasL, seems to protect BAL immune
cells. 4. The major AL subset regulated in ILD lower ai-
rways by apoptosis seems to be CD4 cells.
C23
Expression of interferon-gamma
(IFNg) in BAL fluid of patients with
selected interstitial lung diseases
(ILD). Better prognosis in patients
with increased CD4/CD8 ratio in
pulmonary sarcoidosis (PS) and
idiopathic pulmonary fibrosis (IPF)
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Abstract
Backgroung: IFNγ is active as a potent antifibrotic cytoki-
ne in interstitial lung diseases (ILD). T cells (acc. to Th1/
Tc1 secretion pattern) are regarded as a main local source
of  IFNγ.
Methods: BAL fluid of  101 nonsmoking patients with ILD,
incl. IPF(UIP), PS, extrinsic alveolitis (EA), asbestosis and
silicosis (n=17,50,7,11,16 resp.) was tested for IFNã; levels
(ELISA). Results were completed with BAL immunology/
cytology and referred to clinical data.
Results: Increased IFNγ; levels were observed in non-trea-
ted patients with EA (7.8±2.1), IPF (6.1±1.8) and PS
(7.9±1.7), whereas the results of  pneumoconioses were si-
milar to those obtained in the controls (n=15, 2.0±1.1 pg/
ml, median ± SEM). The highest IFNγ concentration was
found in Loeffgren’s syndrome (10.2±2.4), the PS subgroup
characterized with especially high CD4/CD8 ratio (10.5±1.2
vs progressive PS 5.3±0.7; p<0.05). IFNγ level in ILD was
positively correlated with percentage of  BAL lymphocyte (r
Spearman +0.23; p<0.05), total CD4 cell number (rs +0.32,
p<0.05) and CD4/CD8 ratio (rs +0.38, p<0.0001). In IPF/
UIP group of  patients with CD4/CD8<1 (n=8), IFNγ le-
vel was lower as compared to the group with CD4/CD8>1
(n=9): 2.8±1.3 vs 7.3±1.0 pg/ml. Steroid treatment caused
insignificant decrease in IFNã; levels of  serial lavages in 7
PS and 8 IPF patients.
Conclusions: The results are consistent with the view on
protective role of  IFNγ in ILD and may explain the better
prognosis in patients with higher CD4/CD8 ratio in ILD
with imminent fibrosis. CD4, but not CD8 seem to be the
main local source of  IFNγ in ILD.
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Expression of CCX CKR in pulmonary
sarcoidosis
Eva Kriegova, Andrey Tsyrulnyk, Arsen Arakelyan,
Frantisek Mrazek, Vitezslav Kolek, Roland M du Bois,
Helmut Popper, Martin Petrek
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Abstract
Objective: CCX CKR is a decoy chemokine receptor that
specifically binds the chemokines CCL19, CCL25 and CCL21.
CCL19 was previously found upregulated in pulmonary sar-
coidosis. We have, therefore, investigated CCX CKR expres-
sion and its plausible role in this inflammatory disease.
Methods and results: CCX CKR mRNA was semiquan-
titated by RT-PCR in unseparated bronchoalveolar (BAL)
cells from the sarcoid patients (S, n=29) and control, heal-
thy subjects (C, n=9). CCX CKR transcripts were upregu-
lated in the patients (mean±SEM); S, 0.82±0.10; C,
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0.44±0.04; p=0.01. The highest number of  transcripts was
observed in patients with the most advanced chest X-ray
(CXR) stage III by contrast to the initial stage I (S-I,
0.72±0.10; S-II, 0.85±0.20; S-III, 1.04±0.20, p<0.02). Im-
munocytochemistry localised the CCX CKR protein to ci-
liated bronchial cells. Flow cytometric fluorescent ligand
uptake assay showed that these cells are able to internalize
its ligand.
Conclusion: The CCX CKR expression by ciliated bron-
chial cells from sarcoid patients implicates this receptor in
the modulation of  immune and inflammatory reactions on-
going in the lung. Further investigations are required to cha-
racterise the regulation and functional significance of CCX
CKR expression, mechanism of  internalisation and fate of
the ligand.
Grant support: GACR 310/05/2614, IGA MZ CR NR/9037.
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Sarcoidosis – an unusual neurological
involvement
E Magalhães, F Fradinho, A Franco, S Luís, MF Baganha
Departamento de Ciências Pneumológicas e Alergológicas dos
Hospitais da Universidade de Coimbra. Portugal
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Abstract
The authors present a 39 year-old caucasian male patient,
mason, non-smoker, previously healthy until October/2002
when he had two sequential episodes of  uveitis responding
to topic and systemic corticosteroids. After slow tapering
he developed a neurological syndrome with nystagmus, ri-
ght-sided Horner’s syndrome, hypoesthesia and ataxic he-
miparesis – Wallenberg Syndrome.
Cerebrospinal fluid revealed elevated protein levels. The MRI
scan of  the brain displayed a non-gadolinium enhanced ri-
ght posterior laterobulbar lesion. The thoracic CT scanning
revealed mediastinal and hilar adenopathies. Pulmonary func-
tion tests including carbon monoxide diffusion capacity
(DLCO), flexible bronchoscopy and cardiac evaluation were
normal. Bronchoalveolar lavage was inconclusive. Sarcoidosis
was confirmed by mediastinal lymph node biopsy.
High-dose corticosteroids were re-introduced with gradual
recovery of  neurological deficits.
Therapeutic tapering resulted in recurrence of  ophthalmo-
logic symptoms and appearance of  new pulmonary lesions
with the pulmonary function tests displaying a restrictive
impairment and reduced DLCO (50,1%).
We present this case due to the exuberant neurological
syndrome in a patient already under systemic steroid the-
rapy, discussing the therapeutic options in this type of
involvement.
Key-Words: sarcoidosis; neurological involvement; therapeutic.
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Is it sarcoidosis?
A Campos, J Jones, P Mendes, F Gamboa, A Marques,
A Ferreira, C Leite, C Robalo Cordeiro, M Fontes Baganha
Department of  Pulmonology and Alergology. Coimbra Uni-
versity Hospital. Portugal
ana.rufia@clix.pt
Abstract
The authors describe a clinical case of  a previously healthy
39-year-old woman, with complaints of  dyspnea, dry cou-
gh, chest pain, fatigue and anorexia which started a month
before admission.
The patient was a dressmaker and did not smoke.
Chest radiograph showed a bilateral reticularnodular pat-
tern and therefore additional work-up was carried out. SACE,
serum clacium, 24 h urine calcium, pulmonary function tes-
ts, DLco and 67 Ga scan were normal.
Thoracic CT scan showed “... multiple well defined centi-
metric nodules with precise borders spread throughout both
lung fields...”.
Fibreoptic bronchoscopy showed no endoscopic abnor-
malities. Cytological and microbiological analysis were
normal.Bronchoalveolar lavage (BAL) revealed: 69% mo-
nocytes/macrophages, 3%neutrophils, 0.5% B lymphocytes
and 14% T lymphocytes (68% CD4 T lymphocytes and
26% CD8 T lymphocytes).The CD4 T cells were mostly
of  the Th1 type.
Serum T lymphocytes showed normal phenotype.
CT-guided needle biopsy of  a pulmonary nodule was per-
formed but the result was inconclusive.
The patient underwent surgical lung biopsy which allowed
tissue diagnosis of  sarcoidosis (stage III).
Oral therapy with corticosteroids was prescribed and the
patient was discharged to the outpatient consultation.
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Role of bronchoalveolar lavage
in diagnosis of interstitial lung diseases
– case report
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Abstract
Sarcoidosis is a multisystem inflammatory disease of  unk-
nown etiology that predominantly affects the lungs and
intrathoracic lymph nodes and is manifested by the pre-
sence of  noncaseating granulomas (NCGs) in affected or-
gan tissues.
Pneumoconiosis is the general term for lung disease caused
by inhalation of  mineral dust. Silicosis is a fibronodular lung
disease caused by inhalation of  dust containing crystalline
silica (alpha-quartz or silicon dioxide), which is distributed
widely, or its polymorphs (tridymite or cristobalite), which
are distributed less widely.
Bronchoalveolar lavage (BAL) is a minimally invasive diag-
nostic technique that yields insights into immunologic, in-
flammatory, and infeccious processes occurring at the al-
veolar level being useful in the setting of  interstitial lung
diseases.
The authors describe the case of  a 68 years old woman,
which presents with insidious non-productive cough, calci-
fied and non-calcified limph nodes and parenchimal conso-
lidations and nodules in both lungs on CT scans. She had an
history of  occupational dust (silica) exposure.
BFO with BAL and semi-distal biopsies were performed,
and a diagnosis of  sarcoidosis was achieved.
This case emphasises the contribution of  BAL in the diag-
nosis of  Interstitial Lung Diseases, as well as, the uncom-
mon association of  two fibrotic lung diseases.
P04
Intersticial pneumonia associated
with rapaycin therapy – case report
M Tátá1, L Mota1, J Reimão Pinto2
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Abstract
Rapamycin is a recent immunosuppressive agent used with
increasing frequency in solid organ transplantation. Ho-
wever, it has been associated with rare problems of  pul-
monary toxicity, such as interstitial pneumonia. These ca-
ses improved after dose-reduction or discontinuation of
the drug. The authors present a case of  a 58 year old
male, engineer, non smoker, without occupational expo-
sure risk.
In 1999, he was submitted to renal transplantation for end-
stage renal disease secondary to IgA nephropathy. He was
treated for five years with mycophenolate plus cyclosporine
and prednisolone. Then the treatment was switched to ra-
pamycin and prednisolone. Eight weeks after, he developed
fever and dry cough.
Computed tomography showed evidence of  bilateral ground
glass opacities, with lower lobes predominance.
Lung function tests showed reduced carbon monoxide di-
ffusion (DLCO-52, 4% and DLCO/VA-64,5%); without
hypoxaemia.
Bronchoalveolar lavage (BAL) was negative for P. jiroveci,
CMV, fungi, mycobacteria and bacteria. BAL showed pre-
dominance of lymphocytes with a CD4/CD8 ratio of 2,6.
Transbronchial lung biopsy was compatible with the hypo-
thesis of interstitial pneumonia.
After dose reduction of  rapamycin there was clinical, func-
tional and radiological improvement. Currently, about two
years later, the patient remains stable, with good graft func-
tion and normal lung tests.
Key-words: interstitial pneumonia, rapamycin
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Bronchoalveolar lavage features
in sirolimus induced lung disease
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Abstract
Drug induced lung diseases (DILD) are an increasingly
cause of  morbidity. Many drugs have been described, cau-
sing several patterns of  injury. Sirolimus is an immuno-
suppressive agent increasingly used in renal and other solid
organ transplantation. Pulmonary toxicity has been re-
cognized as a potential complication associated to this
medication. Interstitial pneumonitis and more rarely al-
veolar haemorrhage have been described. BAL can be very
informative in DILD either showing features that, although
not specific, are commonly seen or ruling out other diffe-
rential diagnosis, such as infection or malignancy. Siruli-
mus lung toxicity usually associates with a lymphocytic
alveolitis, mainly of  CD4+ type. The authors describe 4
cases (3 men and 1 woman) between 46-71 years, trans-
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planted three years ago (1 patient) and 7 years ago (3 pa-
tients). All of  them were medicated with micofenolato
mofetil (less than 1 g/day), prednisone (doses between 5
and 10 mg/day) and sirolimus (2 mg/day in 3 patients
and 3 mg/day in 1). All patients referred fever in the ad-
mission; 3 patients complained of dyspnoea and 2 had
productive cough. Diffuse pulmonary infiltrates in HRCT
scan were present in the four patients. BAL showed lym-
phocytic alveolitis in 3 casses, however with a different
CD4/CD8 ratio (high-1, normal-1 and low-1); the BAL
which showed a high CD4+ proportion had also neutro-
philia. The other patient BAL showed severe haemorrha-
ge. Pulmonary infections were ruled out by specific BAL
staining and cultures. After the drug suspension, all pati-
ents experiment an improvement of  the clinical picture.
The BAL features described agree with the available data.
However we found a more variability in CD4/CD8 ratio
that didn’t relate with different clinical or radiological pre-
sentation or even with a different outcome.
Key-words: sirolimus, lung toxicity, bronchoalveoar lavage
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Lymphocytic intersticial pneumonia
in a HIV-positive adult woman
Manuel Fonseca, Ana Cristina Mendes,
Renato Sotto-Mayor, Antonio Bugalho de Almeida
Hospital Santa Maria/Pulmonary Medicine Department, Lis-
bon
fons99@clix.pt
Abstract
Lymphocytic Interstitial Pneumonia (LIP) is a rare lung di-
sease characterized by infiltration of  the interstitium and
alveolar spaces by lymphocytes and plasma cells.
It has a recognized association with AIDS, particularly in
the paediatric population.
The case of  a 36-yr-old HIV-positive woman, who deve-
loped dyspnoea and chronic cough, ground-glass attenu-
ation with areas of  obliterative bronchiolitis on chest CT
and severe functional impairment with hipoxemia at rest,
is reported.
Bronchoalveolar lavage was negative for infection and reve-
aled lymphocytic cellularity. Thoracoscopic lung biopsy spe-
cimens were consistent with LIP.
She was started on Prednisolon 0,75mg/kg/d based on ide-
al weight with marked improvement of  her clinical conditi-
on, radiological changes, pulmonary lung function tests and
abnormal pulmonary gas exchange during formal exercise
testing.
This case illustrates the rare association of  LIP with HIV
infection in adults.
P07
Lymphangioleiomyomatosis: A review
of three cases
C Valente, S André, C Santos, A Catarino, F Fradinho,
F Gamboa, M F Baganha
Departamento de Ciências Pneumológicas e Alergológicas dos
Hospitais da Universidade de Coimbra
carlavalente77@yahoo.com.br
Abstract
Object of study: the authors review three cases for clinical
and radiological findings of  lymphangioleiomyomatosis.
Material: three female patients with 51 years, 42 years, and
34 years.
Methods: the clinical and radiological findings of  each pa-
tient were reviewed.
Results: one patient had a two years right thoracalgia and dysp-
nea. The chest X-ray showed a generalized, symmetric reticulo-
nodular interstitial infiltrate, sparing the lung apices. High resolu-
tion lung computed tomography (HRLCT) showed bilateral
diffuse thin-walled lung cysts with ground glass opacities throu-
ghout all lobes. The other patient presented to the emergency
room with a chylotorax after a car accident with traumatic ruptu-
re of  the thoracic duct. HRLCT showed multiple small non-
confluent thin walled cysts, throughout all the pulmonary lobes,
with varying sizes. The third patient presented with non-produc-
tive cough, dyspnea to major exercise, asthenia, and weight loss.
A chest X-ray demonstrated left pleural effusion. The diagnostic
thoracocentesis revealed pleural liquid with biochemical criteria
of  chylothorax. A posterior HRLCT showed multiple cysts with
varying sizes, thoracic duct ectasia, and a right pleural effusion.
Conclusions: LAM is an uncommon interstitial lung disease
that exclusively affects women, usually during their reproduc-
tive years. Affected patients typically present with dyspnea and
cough. LAM is characterized radiographically by interstitial
reticular opacities that may be subtle or obvious and may pre-
cede, accompany, or follow pneumothorax or chylothorax.
The CT appearance of  LAM is diagnostic when diffuse bila-
teral thin-walled cysts surrounded by normal intervening lung
parenchyma are demonstrated in young women.
P08
Usual interstitial pneumonia
– Case report
E Magalhães, F Fradinho, A Franco, S Luís, MF Baganha
Departamento de Ciências Pneumológicas e Alergológicas dos
Hospitais da Universidade de Coimbra. Portugal
eunice.raquel@sapo.pt
Abstract
The authors present a 50 year-old caucasian female pati-
ent, farmer worker, non-smoker, with a gradual onset of
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persistent non-productive cough, progressive exertional
dyspnea, fatigue, malaise and weight loss. A history of  ar-
terial hypertension and Raynaud phenomenon of  the ex-
tremities was present. End-inspiratory crackles prevailing
in the lung bases were detected on chest auscultation and
peripheral edema was observed. The rheumatologic evalu-
ation was inconclusive.
The complementary evaluation revealed elevated erythro-
cyte sedimentation rate and lactate dehydrogenase, positi-
ve circulating anti-nuclear antibodies with a perinucleolar
pattern. Antibodies anticentromere and anti Scl-70 were
negative.
The chest radiograph revealed a bilateral reticular pattern
with basal predominance and the high-resolution thoracic
CT scanning exposed bilateral peripheral cystic images com-
patible with pulmonary fibrosis and mediastinal adenopa-
thies. Pulmonary function tests were consistent with a res-
trictive impairment with reduced DLCO (49,5%). The resting
arterial blood gases were normal and no dessaturation was
observed during exercise. Bronchoalveolar lavage showed
lymphocytosis (20%) with a normal neutrophil count (2%)
and a CD4/CD8 ratio of 1,49.
The cardiac evaluation demonstrated congestive heart failu-
re, valvular fibrosis and circumferential pericardial effusion.
The pulmonary artery pressure was normal.
The nail fold microscopy was inconclusive. Esophageal ma-
nometry displayed lower esophageal sphincter incompetence
and absent peristalsis in the distal esophagus.
Surgical lung biopsy was performed revealing a UIP pattern.
The patient was submitted to treatment with prednisone and
azathioprine with persistent pulmonary symptoms and wor-
sening of  ventilatory impairment.
At this point the patient still not fulfils the criteria for scle-
roderma, witch remains the most reliable diagnostic hypo-
thesis. Pulmonary and rheumatologic clinical surveillance is
maintained.
Key-words: usual interstitial pneumonia; scleroderma
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Pulmonary echinococcosis
– A case report
BR Rodrigues, ER Magalhães, L Chieira, I Ribeiro,
AS Luís, MF Baganha
Hospitais da Universidade de Coimbra
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Abstract
Echinococcosis or hydatidosis is a zoonosis caused by the
larval stage of  four Echinococcus species, belonging to fa-
mily Taeniidae. Echinococcus granulosus is the most com-
mon and cause cystic hydatid disease, endemic in Portugal.
Humans are one of  the intermediate hosts and the most
frequently involved organs are liver and lungs.
The authors present a case report of  a 76 years old patient,
farmer, presented with a month-history of  fever, persistent
cough with cleary spumtum and a right-sided chest pain.
Despite antibiotherapy there was no clinical improvement.
The etiological study excluded neoplasy, tuberculosis or other
bacterial infection and confirmed the diagnosis of  hepato-
pulmonary cystic hydatidosis. The clinical features presen-
ted in this case were strongly suggestive of  a pulmonary
cyst rupture.
The therapeutic decision consisted in medical treatment with
albendazole, followed by surgical excision of  the hydatid
cysts. The hepatic cyst surgery was performed before pul-
monary intervention, but the patient succumbed during the
procedure.
The authors want to emphasise a clinical entity that is often
fatal, but sometimes under appreciated.
P10
Diagnostic difficulties in clinical
evaluation of interstitial lung diseases
(ILD) – Two case reports
C Ch Loureiro, A Campos, A Aragão, L Carvalho,
MA Marques, MF Baganha
Coimbra University Hospital
cl_loureiro@hotmail.com
Abstract
Introduction: Interstitial lung pathology definite diagnosis nee-
ds a transbronchic or chirurgical biopsy for histological confir-
mation. Nevertheless, some clinical situations make these proce-
dures difficult, namely by the clinical status of  the patient or even
by their refuse. In such cases, the diagnosis is made by conside-
ring clinical, imagiological and cytological information, as long as
fitting in an evolutive and longitudinal classification pattern.
Objective: to present the difficulties in obtaining a definite
clinical diagnosis in two case reports of  ILD, the diagnostic
value of  therapeutics with positive clinical response and the
prognostic value of  bronchoalveolar lavage (BAL).
Methods: we illustrate our objective with two case reports
of ILD:
– clinical data and test results of a 54 years old caucasian
man, presenting with 8 days of  pleuritic chest pain, low
fever and dry cough, after returning from a tropical coun-
try and having done empirical therapeutics with azytro-
micine and NSAI’s. On admission he presented diffuse
pulmonary opacities on chest X-Ray.
– clinical data and test results of a 52 years old caucasian
man, presenting with anorexia, adynamia, myalgias, swe-
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ating and non productive cough for 5 days. While on emer-
gency department he developed an ARDS needing inva-
sive mechanical ventilation with a chest X-Ray showing,
bilaterally, areas of  parenchyma infiltration.
Conclusion: we emphasize the uncommon and severe pre-
sentation of  these two cases of  ILD and the diagnostic and
therapeutic option we have made to achieve a clinical resolution.
P11
Pulmonary alveolar proteinosis
Ricardo Lima, Daniela Ferreira, Ana Rego, Ana Oliveira,
Teresa Schiang, Sofia Neves
Vila Nova de Gaia Hospital Center, Portugal
ricardo9lima@hotmail.com
Abstract
Pulmonary alveolar proteinosis is a rare disorder in which
lipoproteinaceous material accumulates within alveoli. The
clinical course of  the disease is variable, ranging from respi-
ratory failure to spontaneous resolution. An important fea-
ture of  the disease is susceptibility to pulmonary infections,
sometimes with opportunistic organisms.
The authors present the case of  a woman, 59 years-old, non-
smoker sent to Pneumology consultation due to dyspnoea and
dry cough. At physical examination, she had inspiratory crackles
in the inferior two-thirds of  both hemithorax. The chest radio-
graph had a bilateral alveolo-interstitial pattern. Computed to-
mography scanning showed bilateral pulmonary consolidation
and thickening of  the interlobular septa, some regions of  geo-
graphic ground-glass. Pulmonary function tests revealed mild
restrictive defect, with reduction in carbon monoxide diffusing
capacity. Blood gases: pH-7.449; pO2-67 mmHg; pCO2- 60.5
mmHg; HCO3- 24 mmol/L. The bronchoalveolar lavage had
milky appearance, PAS-positive, phospholipoproteinaceous ma-
terial suggesting alveolar proteinosis. She remained in clinical sur-
veillance, without need of  bronchoalveolar lavage, with sponta-
neous and complete resolution after three years of  follow-up.
P12
Pulmonary tuberculosis presenting
as a cavity
C Valente, S André, A Franco, MF Baganha
Departamento de Ciências Pneumológicas e Alergológicas dos
Hospitais da Universidade de Coimbra
carlavalente77@yahoo.com.br
Abstract
Object of study: the authors present an atypical presenta-
tion of  pulmonary tuberculosis.
Material: review of the clinical process of the patient.
Methods: the clinical, laboratorial, and radiological findin-
gs were reviewed.
Results: a 43 years old male patient was referred to our depart-
ment with the radiological and clinical diagnosis of right pneu-
monia and partial respiratory insufficiency. The chest X-ray sho-
wed a round opacity with an air-fluid level and thick walls localized
to the upper right lobe. The lung Computed Tomography de-
monstrated a cavitating lesion at the posterior segment of  the
upper right lobe with an air fluid level. There was an associated
pneumonic infiltrate with air broncogram. During his stay he
made several antibiotics with no clinical and radiological respon-
se. The examination of  the sputum collection revealed no myco-
bacterium tuberculosis as well as the bronchic lavage. The diag-
nosis was established by the culture of  this lavage that identified
Mycobacterium tuberculosis complex. The patient was referred
to the local tuberculosis treatment institute.
Conclusions: tuberculosis may be confused with several
other pulmonary parenchymal infections, with the same cli-
nical and radiological findings. In this case the diagnosis was
made by the culture of  the bronchoalveolar lavage.
P13
Tuberculosis – a cause of spontaneous
pneumothorax
BG Rodrigues, ER Magalhães, L Chieira, AS Luís,
MF Baganha
Hospitais da Universidade de Coimbra
barbara.rodrigues@iol.pt
Abstract
Spontaneous pneumothorax is a rare complication of acti-
ve pulmonary tuberculosis, however, pulmonary fibrosis due
to tuberculous sequel is a common cause for secondary pneu-
mothorax.
The Authors report the case of  a 27 years-old male patient,
smoker, previously healthy, hospitalized with the diagnosis
of  right spontaneous pneumothorax with pulmonary co-
llapse. Chest radiograph, performed after the placement of
a chest tube, showed expanded lungs and bilateral reticulo-
nodular infiltrate.
Test evaluation allowed the diagnosis of  pulmonary tuber-
culosis in a patient with subpleural bullae and residual fibro-
tic lesions.
The patient had a clinical and radiological favourable outco-
me with antituberculous therapy.
In this case, the authors emphasises the fact that a patient
with several risk factors for primary spontaneous pneumo-
thorax – biotype, tabagism, subpleural bullae and residual
fibrotic lesions, had a pneumothorax secondary to pulmo-
nary tuberculosis, which is an infrequent situation.
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Pulmonary tb in patient
with sarcoidosis
MJ Guimarães, C Alcobia, I Ribeiro, L Chieira, AS Luís,
MF Baganha
Departamento de Ciências Pneumológicas e Alergológias dos
Hospitais da Universidade de Coimbra
dr.mariajose@gmx.net
Abstract
The authors describe the clinical case of  a 41 year-old man,
admitted with community acquired pneumonia and hypoxe-
mia in a context of  classical clinical features for respiratory in-
fection extended in time. Personal history for athsma control-
led with appropriate medication, cutaneous sarcoidosis (on
corticotherapy for 1 year, stoped in 1999) and Perthes disease.
Once the clinical diagnose of, cutaneous sarcoidosis was made,
the patient went to the pulmonology physician. He ask for
some complementary study including Bronchoalveolar lava-
ge who revealed a CD4+/ CD8+ of  4,5 who were determi-
nant for establish the diagnosis for systemic sarcoidosis.
The chest x-ray show bilateral consolidation of  the lung paren-
chyma. Direct microscopy was positive for AFB which condi-
tioned the implementation of  antituberculous agents. The spu-
tum culture was positive for Mycobacterium tuberculosis.
Pulmonary TB have increase incidence in immunocompromi-
sed patients, and the corret diagnosis with appropriate therapy
is essential in controlling the disease without lung damage.
This is a clinical case of  the same patient with two granulo-
matous diseases.
P15
pH breath condensate in atopic
wheezing children
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Abstract
Objective: To compare pH in exhaled breath condensate
(EBC), between atopic and non-atopic wheezing patients.
Methods: 53 children with a wheezing history in the last 12
months were selected at primary schools of  a Portuguese
inner-city (Viseu) using the ISAAC questionnaire. All of  them
were submitted to eNO measurements and EBC collection
in order to evaluate bronchial inflammation. EBC pH was
analysed on all samples after deaeration with argon. For those
who were under asthma regular treatment, medication was
stopped three weeks before.
Results: 31 males and 22 females (mean age of  7 ± 1.1
years) were studied. 19 children were sensitized to at least
one airborne allergen and 34 didn’t. For the sensitized chil-
dren, the median value for eNO was 22 ppb (interquartile:
16-32.5 ppb) and the median value for EBC pH was 8.41
(interquartile: 8.29-8.44). For the non-sensitized children, the
median value for eNO was 9 ppb (interquartile: 6.25-14.75
ppb) and the median value for EBC pH was 8.40 (interquar-
tile: 8.20-8.50). Statistical differences were found for eNO
between this two populations (p<0.0005). No differences
were found for EBC pH (p: 0.65).
Conclusions: EBC pH is similar on atopic and non atopic
wheezing patients.
Granted by: Fundação Calouste Gulbenkian, SaudAr Pro-
ject
Supported by: FEDER/ POCTI
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Corticosteroids in sarcoidosis:
A decision rule based approach
P Lopes1, S Freitas2, J Jones2, J Figueira3, S Greco4,
C R Cordeiro2
1 Faculdade de Economia da Universidade de Coimbra
2 Departamento de Ciências Pneumológicas e Alergológicas dos
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3 ISTL
4 Facultà Economia, Universittà Catania
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Abstract
Sarcoidosis is a multisystem disorder of  unknown cause. The
clinical expression, natural history and prognosis are highly
variable, with a tendency to wax and wane, either sponta-
neously or in response to therapy, usually corticosteroids.
The use of  corticosteroid therapy remains controversial, al-
though the perception that progressive symptomatic disea-
se should be treated has become generally accepted. The
criteria applied to evaluate this progression and monitor the
disease over time is in continuous change. Over the last ye-
ars, the application of  Operations Research/Decision Ai-
ding techniques in Medicine has become a useful tool. In
this paper, the authors propose a decision rule based appro-
ach to derive a set of  rules that will define the relevance of
a set of attributes (condition attributes), applied to identify
those patients in need of  corticosteroids therapy (decision
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attribute). From a sample of  33 patients with biopsy-pro-
ven Sarcoidosis, the condition attributes considered were:
age, clinical features, laboratory findings, diffusion capacity,
radiological stage, CT scan, bronchoalveolar lavage, Gallium
scan, and extra-pulmonary involvement. Each of  these at-
tributes had a set of  sub attributes (extra-pulmonary invol-
vement assessed skin, gastrointestinal and ocular lesions (no
patients presented with CNS or cardiac involvement)). Three
condition attributes (age, radiological stage, CT scan) were
considered unnecessary for the decision, while the others
correlated in different degrees with the decision attribute.
Through the application of  Rough Set Theory, decision ru-
les (in terms of  if  these symptoms/findings, then this deci-
sion) were derived after computing the solution of  a Boole-
an function.
P17
Bronchoalveolar lavage
in sarcoidosis: Is there a role
for neutrophils?
Nuno Filipe Pires1, António Morais1, Cláudia Dias2,
Luís Filipe Azevedo2, Carmo Palmares1, Luís Delgado3
1 Pulmonology Department
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nunofxpires@portugalmail.pt
Abstract
Introduction: Lymphocytes percentage in Bronchoalveo-
lar Lavage (BAL), especially CD4/CD8 ratio may be helpful
in establishing the diagnosis of  sarcoidosis. Some studies
suggest a role for neutrophils, especially in what evolution
of  disease is concerned. However, the real association ei-
ther with sarcoidosis main characteristics or with its outco-
me has not yet been established.
Aim: Study of  BAL neutrophils association with clinical,
functional, radiological and outcome in patients with sar-
coidosis.
Material and Methods: 152 patients with sarcoidosis were
included. Clinical presentation, functional, radiological and
BAL features were studied as well as the patients’ outcome.
The statistical analysis was carried out by using SPSS 14.0®
programme.
Results: The mean age was 35 years (17-69) and predomi-
nantly female (64%). Cough (48%), dyspnea (43%) and
erythema nodosum (28%) were the most frequent clinical
presentations. Lung Function Tests: normal-53%, obstruc-
tive pattern-27%, restrictive pattern-13%, mixed pattern-6%.
Radiological stages: I-38%, II-47%, III-8%, IV-7%. Reticu-
lonodular and micronodular were the most frequent radio-
logical patterns. BAL median values: total cell count-2.6x105,
lymphocytes-38%, CD4/CD8-4.5, neutrophils-1%. Extra-
thoracic involvement was present in 30% of  patients. A chro-
nic course was observed in 45% of  patients. We found sta-
tistically significant differences of  neutrophil percentages
among categories of  lung function tests (p=0.027), radiolo-
gical stages (p=0.002) and radiological patterns (p=0.033).
Significantly higher percentage were found for restrictive
pattern (5.5%), radiological stages II and IV (5.8% and 5.9%
respectively), reticular and fibrosis radiological patterns (5.1%
and 8.2% respectively).
Conclusions: According with our results neutrophils see-
ms to have a role in the pathogenesis of  the disease associ-
ated with a more severe presentation. However considering
all the patients studied we haven’t found any influence in the
natural history of  the disease.
P18
The reflection of the diffusion
lung capacity changes on the
bronchoalveolar lavage cytology
in the newly diagnosed sarcoidosis
Luminita Cervis, Cristina Teleaga, Diana Ionita,
Roxana Nemes, Nicoleta Bisca, Aneta Serbescu
“Marius Nasta” Institute of  Pneumology, BAL Laboratory, Sos
Viilor Bucharest, Romania
lumicervis@yahoo.co.uk
Abstract
Background: the presence of  sarcoidic granulomas in the
lung tissue could result in a functional impairment and in
the changes of  the bronchoalveolar lavage (BAL) cellularity.
The most sensitive test for the detection of  the lung invol-
vement is the diffusion lung capacity (DL,co).
Aim: to assess whether different degrees of  the diffusion
lung capacity alteration are reflected in typical patterns of
BAL cytology of  patients with sarcoidosis.
Methods: the retrospective study included 67 patients
(35males), aged 37.1±11.4 years with newly diagnosed sar-
coidosis. All patients underwent chest X-ray and diffusion
capacity of  the lung for carbon monoxide measurement.
The patients were distributed in 4 groups depending on
DL,co value: 1 with normal gas changes, 2 (DL,co 60-80%),
3 (DL,co 40-60%) and 4 (DL,co < 40%). The BAL’s cellular
populations were compared between the groups.
Results: there was no statistical significant difference of
BAL’s cytological pattern between the patients with diffe-
rent values of  DL,co.
Conclusions: the BAL’s cytological features did not reflect
the severity of  the lung functional impairment.
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Bronchoalveolar lavage
in pulmonary sarcoidosis
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Abstract
Aims: Our aim was to evaluate the demographic, clinical, radio-
logical and BAL characteristics of  60 patients with histological/
clinical/laboratorial evidence of  pulmonary sarcoidosis who un-
derwent BAL as part of  their initial diagnostic evaluation. Analyze
the correlation between BAL findings and stage/prognosis.
Method: Retrospective study of  sarcoidosis patients’ files
that underwent BAL. Sixty files were analyzed and the po-
pulation was characterized according to age, sex, radiologi-
cal staging at onset (modified Scadding criteria), DLCO, FVC,
BAL results, histology confirmation and disease course. The
obtained data were analyzed using specific statistic software.
Results: Mean age 36.4 yrs. Female 53.3%, male 46.7%. Radiolo-
gical staging (%): stage I/II/II/IV: 35/53.3/11.7/0. BAL findings
(%): lymphocytic alveolitis 75.4, normal 8.8, lymph/eosin alveolitis:
5.3, lymph/neutr alveolitis 3.5, other 7.1; CD4/CD8 ratio >3.5:
64.6%, increased CD8: 4.2%. DLCO mean 91.8%, FVC mean
87.8%. There was histological confirmation in 51.7%. Treatment
was started in 65%. Complete remission was achieved in 23.3%
of all patients. 20% patients had progression of  the disease.
We did not find any relationship between neutrophylic alve-
olitis and lung function or evolution of  disease. Statistic sig-
nificance was found between neutrophylic alveolitis and
worse stage (Chi-square test, p<0.05)
We did not find any relationship between CD4/CD8 ratio
and stage or disease course or lung function.
P20
High report of tuberculosis among
brick workers could be an
occupational factor?
Firoozeh Eslami; Majid Avijgan; Fariba Farid
Shahr-e-kord University of  Medical Sciences; Islamic Republic
of Iran
avijgan@yahoo.com
Abstract
Object of  Study: At present and after HIV epidemic, TB is
the second infectious disease in the world. Somebody is high
risk for TB involvement and they could be involved under
some occupational factors. One of  them is Brick workers
who are exposed for some occupational and environmental
factors which are irritant for lung. The main purpose of  this
study is passive case finding and report of  incidence and
prevalence of  TB among Brick workers of  Isfahan Provin-
ce, Iran.
Materials and Method: By considering of data of centre
of  health department of  Isfahan (2000-2005) and also data
of  TB for Brick workers of  Isfahan, their demographics
characteristic have been recorded.
Results: On The base of  results of  this study, the brick
workers are situated in 3 areas of  Isfahan. In these areas the
report of  incidence of  TB among Brick workers are as fo-
llow: Isfahan (16.2%, 33.9%), Aran-Bidgol (9.1% -20%) and
Borkhar-Meymeh (14.7% -44.4%).
Summaries and Conclusions: By considering of these re-
sults, Borkhar-Meymeh and Aran-Bidgol are reported to have
highest (44.4%) and lowest (9.1%) of  TB report.
It seems this finding have a direct relation with number of  bri-
ckers and number of  non residential workers (Afghanis) in the-
se areas. On the base of  these reports and also the probable
relation of  TB incidence and occupational factor, it suggests
having a more observation and following up for these workers.
Key-words: Brick workers, Occupational health, TB
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Natural killer T cells (NKT)
in bronchoalveolar lavage
of patients with sarcoidosis
Katarina Osolnik, Peter Korošec, Izidor Kern
University Clinic of  Respiratory and Allergic Diseases
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Abstract
Introduction: NKT cells are a lymphocyte subset that is
distinct from conventional T cells and NK cells. They coex-
press T and NK receptors and may represent cytolytic effec-
tor T cells or distinct T cell lineage such as CD1d-restricted
NKT cells, which are unique in their rapid production of
large quantity of  both Th1-biased and Th2-biased cytoki-
nes, particularly IFN-, TNF and IL-4. It was recently sho-
wed that NKT cells could also play an important role in
immunologically mediated interstitial lung diseases.
The AIM of  our study was to examine the pulmonary NKT-cell
numbers and distribution in bronchoalveolar lavage (BAL) in
patients with acute sarcoidosis manifesting as Löfgren’s syndro-
me and in patients with newly diagnosed, untreated sarcoidosis.
Materials and Methods: We included 62 patients (35F,
27M) classified into two groups: Löfgren’s syndrome (9F,
5M) and others (26F, 22M). BAL was performed with flexi-
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ble fiberoptic bronchoscope (Olympus Optical Co Ltd,
Tokio, Japan). The phenotypes of  BAL lymphocytes were
determined by flow cytometric analysis in specimens with
>15% of  lymphocytes, using FITC or PE conjugated mo-
noclonal antibodies. Natural killer T cells (CD3+CD16/
56+), helper (CD3+CD4+) and suppressor (CD3+CD4+)
T cells, NK cells (CD3+CD16/56+) and B lymphocytes
(CD3-CD19+) were scored in percentages of  lymphocytes.
Results: We found slightly higher frequency of  pulmonary
NKT cells in patients who were presented with Lofgren’s syn-
drome (median (range); 4% (1-15)) in comparison to those with
newly diagnosed, untreated sarcoidosis (2% (0-16), but not to
statistical significance (P=0.073; Mann-Whitney test). There was
no significant difference between other lymphocytes subsets.
Conclusions: These results suggest the possible role of  NKT
cells in regulating inflammatory process in acute sarcoidosis,
however further studies are needed to confirm these results.
P22
Study of medicinal effect of
roncoleikin in vitro at macrophages
of bronchoalveolar fluid
EP Kalinina, NS Zhuravskaya, TP Gerasimenko
Vladivostok Branch GU of  the Far Eastern Science Centre of
Physiology and Respiration SB RAMS – The Institute of  Medical
Climatology and Rehabilitation, Vladivostok.Russia
elenaimcvl72@mail.ru
Abstract
It has been worked out the model for investigation of  ron-
coleikin medicinal effect in vitro at phagocytes of  broncho-
alveolar fluid. Bronchial lavage was centrifugated at 1,5ths
revolutions per minute during 10 minutes. Roncoleikin was
added to incubative mixture in concentration 250 and 2,5
mg per 1ml of  incubative mixture. Period of  incubation of
bronchoalveolar lavage cellular elements with preparation
made 30 minutes at 37&#730;C. Phagocytic activity and res-
piratory metabolism of  imunnocompetent cells were esti-
mated by the modified method Park, prodigiosan was used
as activator.
Roncoleikin in concentration 250mg in 1 ml of  incubative
mixture rose phagocytic activity of  immunocompetent cells
per 12,6%±0,9% (p<0,001), total quantity of  actively meta-
bolic phagocytes per 23%±1,4 (p<0,05) and the level of
intracellular metabolism of some cells of monocytic-ma-
crophage link per 0,19%±0,04 (p<0,05). Roncoleikin addi-
tion in concentration 100 times less the previous one didn’t
influence on immunologic parameters. Roncoleikin in vitro
in concentration 250mg in 1ml 0f  incubative mixture im-
pacts on activity and intracellular metabolism of  phagocyts
in bronchoalveolar fluid.
P23
Comparison of alveolar cell
populations, nk and nkt cells between
cop/boop and eosinophilic pneumonia
D Papakosta, K Manika, G Kyriazis, T Kontakiotis,
N Manolakoglou, D Gioulekas, D Bouros, D Patakas
Department of  Pneumonology, Aristotle University of  Thessa-
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Abstract
Aim of  the study: To evaluate bronchoalveolar lavage fluid
(BALF) findings in patients with COP/BOOP and eosino-
philic pneumonia (EP) and to investigate any potential di-
fferences between these two groups.
Patients and Methods: BALF from 59 patients (32 COP/
BOOP and 27 EP, mean age 58.03 5 &#61617;17.51 years)
were analyzed. BALF total cells and cell differentials were
counted while CD3+, CD4+, CD8+, CD19+ and cytotoxic
lymphocytes CD3-CD16/56+ (NK cells) and CD3+CD16/
56+ (NKT cells) were determined by flow cytometry.CD4/
CD8 ratio was also calculated.
Results: Statistically significant differences between COP/
BOOP and EP were observed in percentages of  lympho-
cytes (p= 0.000), eosinophils (p=0.000) and NKT cells
(p=0.001). No differences were observed in CD4 and in CD8
cells between the two groups. In patients with COP/BOOP a
significant negative correlation between NK and T- cells was
observed (p=0.000, r=-0.684) whereas in patients with EP a
significant positive correlation between percentages of  eosi-
nophils and NK-cells was observed (p=0.000, r=0.846).
Conclusions: Though both groups showed similar cell pro-
files in CD8 and NK cytotoxic cells, they displayed different
profiles concerning NKT cells.
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BOOP – Experience of a pulmonology ward
Ana Luísa Fonseca1, Manuela Meruge2, Fernando Matos1,
Fernando Barata1, Ana Arrobas1, Yvette Martins1.
1 Serviço de Pneumologia
2 Serviço de Anatomia Patológica
Centro Hospitalar de Coimbra (CHC)
Abstract
BOOP (Bronchiolitis Obliterans Organizing Pneumonia) is a phy-
siopathologic syndrome associating suggestive clinical and ima-
ging features, together with histopathologic studies showing buds
of connective tissue in the lumen of  the distal pulmonary airspace.
Bronchoalveolar lavage (BAL) may assume characteristic
patterns and help in differential diagnose.
The study is a retrospective review of  all patients with BOOP,
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diagnosed in the Pulmonology Ward of  CHC, between 2000
and 2005.
Eleven cases were diagnosed. Six patients were female and five
were male; average age was in 54,8 years; ten patients were non-
smokers and one was ex-smoker; five patients had co-morbiditi-
es; mean duration of  symptoms was 62,1 days; initial symptoms
were dyspnea (8 patients), cough (7 patients), fever (5 patients)
and weight loss (2 patients); the majority (9) of  patients had been
given multiple antibiotics before the diagnosis; crackles were heard
in 6 patients, fever in 6 patients and tachypnea in 5; chest X-ray
showed bilateral alveolar opacities in 6 cases, focal pneumonia in
3, linear opacities in 1 and multiple bilateral nodes in 1; lung func-
tion testing, performed in 7 patients, showed a reduction in the
diffusion capacity in 5 (average DLCO/VA of  67.1%); BAL was
performed in 8 patients, and revealed an increase in the percenta-
ge of  lymphocytes in 7, with CD4/CD8 of  1.4 in average; histo-
pathologic studies of  pulmonary biopsy were diagnostic in all
cases; nine patients were given corticosteroids; resolution was
favourable in all patients except one who died.
Of  the parameters we looked at we emphasize: the presence
of symptoms during long periods before diagnosis and ad-
ministration and failure of  multiple systemic antibiotics;
agreement between imaging and those published in the lite-
rature; the increase in lymphocytes in the BAL, although the
ratio CD4/CD8 was not usefull for diagnosis; the good res-
ponse to corticosteroids and non recurrence in our patients.
Key-words: BOOP, Bronchoalveolar Lavage (BAL).
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expressed in lower airways
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diseases (ILD) is active as mitogen
of immune cells and antiapoptotic
protective agent of epithelia
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Abstract
Background: Alveolar macrophages (AM) are known as a
source of  IGF-I in lower airways. Little is known about ex-
pression of  IGF-I in other alveolar cells, incl. lymphocytes
(AL), and about a local role of  this cytokine in physiological
conditions and in ILD.
Materials and Methods: BAL was carried out in patients
with silicosis, asbestosis, idiopathic pulmonary fibrosis (IPF)
and sarcoidosis (n=13, 8, 12, 56, resp). AM and AL were
studied for a) IGF-I, IGFR1, BCL-2, Fas and Fas Ligand
expression; b) cell cycle (incl. sub-G1 apoptosis peak); c)
TUNEL. IGF-I levels in BAL supernatant were examined
with ELISA. A549 cells were cultured as a model of  lower
airway epithelial cells.
Results: IGF-I was present in AL of  all tested groups. The
number of  IGF-I+ AL was significantly higher in IPF (52 ±
6.7%) and in sarcoidosis (48 ± 5.7 vs 29 ± 6.3% in controls,
p<0.05). ELISA-tested IGF-I levels were significantly in-
creased in asbestosis and Loeffgren’s syndrome (18,9± 5.7
and 19.1± 3.5 resp. vs 10.3± 1.3 ng/ml in controls, p<0.05).
IGF-I expression in lower airways did not correlate to VC
and other lung function tests. Percentage of  IGF-I+ AL
was significantly correlated with parameters reflecting AL
and AM cell proliferation (e.g. AL IGF-I+ vs AM in S phase
of cell cycle: rs +0.50, p=0.001) and with BCL-2 expression,
but not with apoptosis. However, IGF-I antiapoptotic activity
was found in epithelial cells, since A549 cells transfected
with vector pMT-AG-TH Anti-IGF-I (which tergets IGF-I
gene promoter) demonstrated massive apoptosis, increased
percentage of  FasL+ cells and proliferation inhibition.
Conclusions: 1. AL express IGF-I in normal conditions
and in ILD, especially in IPF and sarcoidosis. 2. In our
material there was no evidence for profibrotic activity of
IGF-I. 3. The cytokine seems to be active as mitogen of
alveolar immune cells and antiapoptotoc protective agent
for epithelia.
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Multinucleated giant cells in BALF
– Granulomatous vs non-
-granulomatous ILD
Silvana Smojver-Je ek1, Bo ica Vrabec-Branica1,
Tatjana Peros-Golubicic2, Jasna Tekavec-Trkanjec2
1 Department of  Cytology
2 Department of  Pulmology
University Hospital for Lung Diseases “Jordanovac” Jordanovac
104, Zagreb, Croatia.
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Abstract
Aim: To estimate the frequency and type of  multinucleated
giant cells (MGC) in BAL fluid of  the patients with ILD
and possible differences between granulomatous and non-
granulomatous diseases.
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Materials and Methods: Retrospectively 44 BAL fluid spe-
cimens of  patients with ILD were examined. Granuloma-
tous ILD were diagnosed in 22 patients (17 sarcoidosis, 4
tuberculosis and 1 histiocytosis X), and in other 22 patients
non-granulomatous ILD (10 IPFs, 1 asbestosis, 1 eosino-
philic infiltrate, 3 lung manifestations of  collagen-vascular
diseases and 7 non-specified ILD). MGC were cells having
3 or more nuclei, separated in groups according to cytomor-
phological features and number of  nuclei. Frequencies, dis-
tribution of  MGC in BAL fluid of  granulomatous and non-
granulomatous ILD and differences among frequencies in
MGC groups were calculated.
Results: MGC were classified in 3 groups: alveolar macro-
phage–like (AM-MGC), Langhans or foreign body type
MGC (LF-MGC) and non-specific MGC (NS-MGC). Num-
ber of  MGC in non-granulomatous ILD was higher (n=191)
than in granulomatous ILD (n=177), without statistical sig-
nificance. Number of  LF-MGC was statistically higher (p<
0,05) in granulomatous ILD. Number of  AM-MGC was sta-
tistically higher (p<0,05) in non-granulomatous ILD.
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Diversity of BAL cell profiles
in interstitial lung diseases
Izidor Kern, Katarina Osolnik, Damjan Er en,
Milivoj Mermolja
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Slovenia
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Abstract
Characteristic BAL cell profiles are defined for common ILD
and expressed as average values. BAL cell distribution pat-
tern in ILD differs from normal type. Object of  study was
to determine cell frequency distribution and to show mixed
cell profiles in ILD.
We analyzed 521 BAL specimens of  ILD (308 sarcoidosis,
60 EAA, 89 IPF, 64 CVD with lung involvment). Specimens
were representative (recovered volume of  instilled fluid
>30%, cell viability >60%, TCC >50 cells/μl, epithelial ce-
lls <10%). Cell differentials were done by counting 200 ce-
lls. Lymphocytic subpopulation were determined by flow
cytometry in specimens with >15% lymphocytes. Univari-
ant analysis was used to test for normal distribution, and
analysis of  variance was used to compare differences betwe-
en average values. Tukey’s test was used to find the means
that are significantly different from each other.
26% specimens of  sarcoidosis had normal value of  TCC.
Lymphocytosis was observed in 76% of  specimens and
half of specimens had only lymphocytic increase while
others were of  mixed type. 45% of  specimens had CD4/
CD8 >5 and 42% of  specimens had normal or decreased
CD4/CD8. Neutrophils and/or eosinophils were slightly
or moderatly increased. EAA had significantly higher ave-
rage value of  TCC than sarcoidosis. There were more spe-
cimens with the highest values of  TCC. Extreme lympho-
cytosis was frequently observed and was part of  mixed cell
profile. Only 6% of  specimens had increased CD4/CD8.
Most of  specimens in IPF had increased TCC. Mixed cell
alveolitis was the commonest type and usually with decre-
ased CD4/CD8. Similar to sarcoidosis, in CVD 25% spe-
cimens had normal TCC. Lymphocytosis was observed in
one third of  specimens. There was mixed cell alveolitis with
increase of  neutrophils, eosinophils and macrophages.
CD4/CD8 was decreased.
We conclude that mixed type of  BAL cell profile with incre-
ased TCC and decreased CD4/CD8 is the commonest in
EAA, IPF and CVD. Pure lymphocytic alveolitis with signi-
ficantly increased CD4/CD8 is common in sarcoidosis.
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Pulmonary alveolar microlithiasis:
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Nesrin Mogulkoc, Serdar Soyer, Ali Veral
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Abstract
Pulmonary alveolar microlithiasis (PAM) is a rare idiopathic
condition that is relatively common among Turks. About
half  the reported cases involve more than one member of  a
family, but the genetics of  inheritance remains uncertain.
We report on an initially asymptomatic, nonsmoking 24-year
old Turkish man, with PAM followed over a period of  twel-
ve years. He presented in 1994 with Guillain Barre Syndro-
me, from which he made a rapid recovery. However, he was
found to have an abnormal chest x-ray with diffuse alveolar
and nodular infiltrates in both lungs. Thoracic CT showed
diffusely distributed dense micronodular opacities. Fiberoptic
bronchoscopy showed no endobronchial pathology. Bron-
chial washings and bronchoalveolar lavage were negative for
acid-fast bacilli and malignant cells but showed a microlith.
A transbronchial biopsy secured a diagnosis of  PAM. A ra-
dioisotope bone scan showed diffuse and intense uptake
throughout both lungs. At this time, he had no respiratory
symptoms. All first-degree relatives were examined and one
brother was found to have radiologically more severe PAM.
Over a period of  tewelve years, the proband s FVC has de-
clined an average fall of  46 ml/year. His FEV1 has fallen by
70 ml/year.
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Abstract
Background: Suberosis is a hypersensitivity pneumonitis-
immunologically mediated, resulting from repeated inhala-
tion of moldy cork dust.
Aim: Characterization of  two different groups in a portu-
guese population with Suberosis.
Material and methods: Retrospective study based on files
analysis from patients with Suberosis at 1986 and 20 years
after chosen in an alleatory way. Characterization: age, sex,
smoking habits, co-morbidities, clinical and radiological pre-
sentation, lung funtion and bronchoalveolar lavage (BAL).
Results: 32 patients, mean age of  39±4.3 yrs, male-81.2%, fema-
le-18.8%. Two groups of  presentation: subacute-8 (I) and chro-
nic-24 (II); mean exposure of 22.4±12.2 yrs; mean time cessati-
on of  10.1±3.0 yrs. We analised clinical behaviour and lung
function at diagnosis and 20 years later. BAL and radiology were
performed at exposure. Restrictive defect and lung diffusion
(DLCO) impairment were the most frequent functional abnor-
mality, particularly in group I. DLCO improved after work cessa-
tion. BAL revealed high cellularity-lymphocytic alveolitis with
50.64±12.7% lymphocytes. BAL CD8+ lymphocytes predomi-
nated and all had CD4/CD8 ratio < 1. Lymphocitosis was hi-
gher in group I – 59.56%. Ground glass opacities were the pre-
dominant radiological pattern in HRCT in group I – 50%.
Comments: Subacute and chronic presentations predomi-
nate in Suberosis. Clinical behaviour of  these groups have
subtle differences. Intensity of  exposure may be important,
but new biomarkers and more studies are needed.
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Abstract
This study aims to describe the correlation between indu-
ced sputum inflammatory cells bronchial hyperreactivity
and lung function in adolescents with well-controlled as-
thma. In 34 atopic adolescents (mean age 12.7+3.4yrs; 14
females) with stable asthma, taking a median dose of 400
μg inhaled corticosteroids (ICS) per day, bronchial hyper-
reactivity to methacholine (PD20M), lung function (for-
ced expiratory volume in one second (FEV1), and induced
sputum cellularity were assessed. Sputum was induced by
hypertonic (4.5%) saline inhalation and cell counts were
expressed as non-squamous cells percentage. Correlations
between variables were assessed by the Spearman correla-
tion coefficient (rs). A satisfactory induced sputum sam-
ple was obtained in 19 (56%) of  the subjects. After spu-
tum induction peak expiratory flow values were similar to
those at pre-salbutamol baseline with a difference of
0.3±19.9 L/min. Sputum contained, median (range), non-
squamous cells 1.0(0.2-3.3)x106ml-1, with 51.4% (10.8-
69.2) macrophages, 15.5% (1.6-68.3) neutrophils, 4.0% (0.7-
13.5) lymphocytes, 2.0% (0-46.1) eosinophils and 18.1%
(3.1-32.4) bronchial epithelial cells. Correlations between
sputum eosinophils and PD20M (rs=-0.45, p=0.124) and
FEV1 (rs=-0.40, p=0.089) were moderate but failed to re-
ach statistical significance. No correlations between abso-
lute cell counts and PD20M and FEV1 were observed.
Sputum induction was a safe procedure although only pos-
sible in a limited proportion of  the subjects. In this group
of  patients, with stable asthma and receiving inhaled corti-
costeroids, sputum inflammatory cells were not correlated
with bronchial hyperreactivity. These results further support
the dissociation of  bronchial inflammation and hyperre-
activity in steroid treated stable allergic asthma.
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Abstract
Introduction: CD103, a receptor for the epithelial cell li-
gand E-cadherin, has been reported to be preferentially ex-
pressed in terminally differentiated mucosal intra-epithelial
lymphocytes, and suggested to be involved in the recruit-
ment of  lymphocytes to lung epithelial surface. BAL CD4 T
cells expressing CD103 have been reported to be in various
amounts in diverse ILD, suggesting a role in some of  this
diseases.
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Aim: comparison of  BAL CD103 expression in bronchoal-
veolar T cell subpopulations in Sarcoidosis and other inters-
titial lung diseases (ILD) patients.
Material and Methods: CD 103 expression was investiga-
ted in BAL lymphocytes of  42 patients (median age 39±16
years; 20 men and 22 women). CD2, CD3, CD4, CD8, CD19
and CD56 expression was also assessed by flow cytometry.
Twenty one patients had Sarcoidosis with thoracic involve-
ment (stage I-10, stage II- 7, stage III-2, stage IV-2). Pneu-
moconiosis, lung involvement by Connective Tissue Disea-
ses, Hypersensitivity Pneumonitis and Idiopathic Pulmonary
Fibrosis were the pathologies presented in the other 21 pa-
tients. Appropriate descriptive statistics were calculated; com-
parisons between groups were performed using non-para-
metric Mann-Whitney U or Kruskal-Wallis tests as
appropriate.
Results: Sarcoidosis patients have the followed results:
lymphocytes 43.2±16.4%, CD4 70.8±16, CD8
19.7±15.2, CD4/CD8 6.5±5.4, CD4+103+ 30.9±32.9
(median 11.6) and CD8+103+ 43.9±32.2. Otherwise the
other ILD patients revealed lymphocytes 52±24.4, CD4
41.2±21.9,  CD8 47.7±20.6,  CD4/CD8-1.3±1.3,
CD4+103+ 46.7±28.8 (median-33.8) and CD8+103+
66.9±27.9. We found a significant lower number of  the
BAL CD103+ CD4+ subset in Sarcoidosis patients,
comparatively with other ILD patients (p=0.026); in
contrast no statistical difference was noted in the
CD8+103+ subsets.
Conclusions: a selective decrease of  CD103 expression cha-
racterizes BAL CD4+ lymphocytes in Sarcoidosis, compa-
ratively to other ILD. As CD103 is a characteristic molecule
of  mucosal T lymphocytes, our data further support the
hypothesis of  a redistribution and alveolar compartmentali-
zation of peripheral blood CD4+ lymphocytes in Sarcoido-
sis, rather than an expansion of  intraepithelial terminal di-
fferentiated cells.
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